source
- IQVIA and Veeva deepen partnership to accelerate clinical trial timelinesIQVIA and Veeva Systems announced an expansion of their existing collaboration aimed at speeding up clinical trial execution and improving efficiency. The upgrade brings Veeva's trial management t…
- BioNTech’s mRNA cancer vaccine misses key endpoint in head-and-neck trial, study to continueBioNTech reported that its mRNA cancer immunotherapy BNT113 did not improve progression‑free survival when added to Keytruda in patients with HPV16‑positive head and neck squamous cell carcinoma. T…